In recent years, there has been growing attention around emerging infectious diseases and the need for faster testing in clinical settings. While many rapid tests focus on common respiratory infections, healthcare providers are also looking for quicker ways to assess less commonly discussed conditions like Hantavirus.
PoC Diagnostics is now providing the Hantavirus IgM Rapid Test Cassette, a professional-use rapid test designed to help support the early assessment of Hantavirus infection, including Haemorrhagic Fever with Renal Syndrome (HFRS).
The test provides results in around 10 to 20 minutes and can be used with whole blood, serum, or plasma samples, making it suitable for point-of-care use in a range of healthcare environments.
Why Hantavirus Testing Is Important
Hantavirus infections can be difficult to identify early because symptoms often overlap with other viral illnesses. Patients may experience fever, fatigue, headaches, muscle pain, or flu-like symptoms during the initial stages.
This is where rapid tests can help support quicker clinical assessment.
While rapid testing is not intended to replace confirmatory laboratory methods, it can help healthcare professionals make earlier decisions about patient evaluation and next steps.
As awareness around emerging infectious diseases continues to grow, there is increasing interest in rapid diagnostic tools that can support faster screening and outbreak response workflows.
Designed for Point-of-Care Use
One of the key advantages of the Hantavirus IgM Rapid Test is its ease of use in professional healthcare settings.
The test:
- Delivers results in 10 to 20 minutes
- Uses whole blood, serum, or plasma samples
- Does not require specialised laboratory infrastructure
- Has a storage range of 4°C to 30°C
- Includes a 12-month shelf life
These features make the test practical for healthcare environments where quick access to diagnostic information is important.
At PoC Diagnostics, we understand that healthcare teams need rapid testing solutions that are simple to use while still supporting reliable clinical workflows.
Understanding How the Test Supports Clinical Assessment
The Hantavirus IgM Rapid Test is intended to be used as an aid in the rapid differential diagnosis of Hantavirus infection in individuals with signs and symptoms consistent with the disease.
It is important to understand that rapid tests should always be interpreted alongside clinical findings and patient history.
Positive or reactive results should be confirmed using confirmatory methods such as PCR or ELISA. Negative results do not fully rule out infection.
This is standard practice in infectious disease diagnostics, where rapid testing often supports early assessment while laboratory confirmation provides additional clinical certainty.
A Growing Focus on Rapid Infectious Disease Testing
Healthcare systems are increasingly moving toward faster and more accessible diagnostic solutions, especially in settings where timely decisions are important.
Point-of-care rapid tests are becoming more widely used because they help reduce delays and improve access to initial diagnostic information.
The introduction of the Hantavirus IgM Rapid Test reflects this growing focus on practical infectious disease testing solutions that can support healthcare professionals in real clinical environments.
At PoC Diagnostics, we continue expanding our rapid testing portfolio to support healthcare providers with reliable and accessible diagnostic tools.
Product Specifications
Product Details
- Product Code: GCHV(IgM)-402a
- Packaging: 25 tests per kit
Sample Types
- Whole blood
- Serum
- Plasma
Storage Conditions
- Store between 4°C and 30°C
- Do not freeze
- Avoid direct sunlight
Materials Included
- 25 test cassettes
- 1 buffer (0.01M PBS)
- Instructions for Use (IFU)
Important Information
The Hantavirus IgM Rapid Test currently carries CE marking for professional use. FDA approval is still pending.
The product is also not yet registered with the MHRA in the UK at the time of writing.
The test is intended for professional in vitro diagnostic use only and should not be used as the sole basis for diagnosis or treatment decisions.
Looking Ahead
Rapid diagnostic testing continues to play an important role in improving access to early clinical assessment, especially as healthcare providers prepare for a wider range of infectious disease challenges.
At PoC Diagnostics, we remain focused on supporting healthcare professionals with practical point-of-care testing solutions designed for modern clinical environments.
To learn more about the Hantavirus IgM Rapid Test or request additional information, contact our team today.
Frequently Asked Questions
What is the Hantavirus IgM Rapid Test used for?
The test is used to help support the rapid differential diagnosis of Hantavirus infection, including HFRS, in individuals showing compatible symptoms.
How quickly does the test provide results?
Results are available within approximately 10 to 20 minutes.
Can this rapid test replace confirmatory laboratory testing?
No. Positive results should be confirmed with methods such as PCR or ELISA, and negative results should be interpreted alongside clinical findings.